New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Modular Medical, Inc.

MODD

Healthcare Medical Devices

EPS
n/m
Free cash flow
n/m

Quarter to September 2026, against a year earlier

1.91 0.09 +4.95%
Market cap
$17.7M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
−263.1%
Net debt / EBITDA
0.3×
Payout ratio
—

Modular Medical, Inc. (MODD) news

The news and the share price important stories, numbered as below

Share price since 20 October −2.3%

Stories the last two months, newest first

  1. 1 Deal ·

    Modular Medical secures coverage agreements with the three largest PBMs

    Modular Medical secured coverage agreements with the remaining two of the three largest U.S. PBMs for its Pivot tubeless insulin pump, joining a previously announced agreement. The PBMs collectively cover more than 182 million people and process about 80% of U.S. prescription claims, potentially supporting broader access across commercial, Medicare, and Medicaid plans.

    Reported by ACCESS Newswire

  2. Other ·

    Modular Medical CEO to discuss Pivot rollout and 2027 launch plans

    Modular Medical CEO Jeb Besser will provide an update on the Pivot tubeless patch pump’s phased rollout across five U.S. regions and progress toward a planned full-scale launch in 2027 during a virtual fireside chat on November 19, 2026.

    Reported by ACCESS Newswire

  3. Other ·

    Modular Medical completes patient market research study for Pivot

    Modular Medical completed a three-phase study with Thrivable involving more than 540 people with diabetes, finding broad interest in simpler insulin delivery and its Pivot tubeless patch pump. About 90% of surveyed MDI users would consider a simpler option, and 82.8% of highly burdened participants would discuss Pivot with a healthcare provider. The findings will inform patient education and commercialization planning.

    Reported by ACCESS Newswire

More headlines